BALSM MEDICAL

Balsm Alofoq Medical Company

9620StocksTadawulHealthcareMarket open

SAR 23.35

Last traded price

0.0%

Price as of June 25, 2026 · --:--

Prices may be delayed by up to 30 minutes.

Financials

BALSM MEDICAL

Balsm Alofoq Medical Company

9620StocksTadawulHealthcareMarket open

SAR 23.35

Last traded price

0.0%

Price as of June 25, 2026 · --:--

Prices may be delayed by up to 30 minutes.

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Assets
Cash & Equivalents	10.84M	18.24M	3.68M	5.74M
Cash & Short-Term Investments	10.84M	18.24M	3.68M	5.74M
Receivables	809.77K	621.75K	343.34K	317.54K
Inventory	3.56M	1.72M	1.50M	0.68M
Current Assets	20.60M	21.20M	5.80M	7.39M
PP&E	15.04M	12.08M	12.86M	7.51M
Total Assets	35.65M	33.28M	18.66M	14.90M
Liabilities
Accounts Payable	251.10K	272.68K	340.97K	441.25K
Current Liabilities	2.01M	1.64M	1.52M	4.37M
Total Debt	1.51M	1.80M	1.93M	2.62M
Total Liabilities	4.76M	4.36M	4.27M	7.54M
Equity & Ownership
Retained Earnings	5.89M	6.27M	4.39M	2.46M
Total Equity	30.89M	28.92M	14.39M	7.36M
Net Debt	-9.33M	-16.44M	-1.75M	-3.11M
Shares Outstanding	2,500,000	2,500,000	1,481,420	—
Cash & Assets
Total Assets	35.65M	33.28M	18.66M	14.90M
Total Current Assets	20.60M	21.20M	5.80M	7.39M
Cash & Equivalents	10.84M	18.24M	3.68M	5.74M
Cash & Short-Term Investments	10.84M	18.24M	3.68M	5.74M
Net Cash (Debt)	9.33M	16.44M	1.75M	3.11M
Net Cash Per Share	3.73	6.58	1.19	—
Cash Growth	-40.6%	+396.0%	-35.9%	—
Net Cash Growth	-43.2%	+838.0%	-43.7%	—
Accounts Receivable	698.96K	341.67K	302.21K	299.64K
Other Receivables	110.80K	280.08K	41.13K	17.90K
Receivables	809.77K	621.75K	343.34K	317.54K
Inventory	3.56M	1.72M	1.50M	0.68M
Prepaid Expenses	73.25K	25.98K	—	—
Construction In Progress	1.24M	—	—	—
Land	7.79M	5.13M	5.13M	—
Buildings	3.36M	3.36M	3.36M	—
Machinery	6.71M	6.46M	6.27M	6.17M
Leasehold Improvements	1.14M	1.13M	1.11M	2.55M
Property, Plant & Equipment	15.04M	12.08M	12.86M	7.51M
Other Current Assets	5.31M	0.59M	0.28M	0.66M
Long-Term Leases	1.29M	1.50M	1.69M	2.13M
Current Portion of Leases	227.23K	308.48K	234.94K	497.36K
Liabilities & Obligations
Total Liabilities	4.76M	4.36M	4.27M	7.54M
Total Liabilities & Equity	35.65M	33.28M	18.66M	14.90M
Total Current Liabilities	2.01M	1.64M	1.52M	4.37M
Accounts Payable	251.10K	272.68K	340.97K	441.25K
Accrued Expenses	983.21K	793.62K	842.32K	621.62K
Current Income Taxes Payable	546.88K	264.20K	96.75K	120.54K
Other Current Liabilities	—	—	0.01M	2.69M
Pension & Post-Retirement Benefits	1.46M	1.23M	1.06M	1.04M
Debt & Funding
Total Debt	1.51M	1.80M	1.93M	2.62M
Equity & Book Value
Shareholders' Equity	30.89M	28.92M	14.39M	7.36M
Common Stock	25.00M	12.50M	10.00M	4.90M
Additional Paid-In Capital	—	10.15M	—	—
Retained Earnings	5.89M	6.27M	4.39M	2.46M
Book Value Per Share	12.36	11.57	9.71	—
Tangible Book Value	30.89M	28.92M	14.39M	7.36M
Tangible Book Value Per Share	12.36	11.57	9.71	—
Filing Date Shares Outstanding	2.50M	2.50M	1.48M	—
Total Common Shares Outstanding	2.50M	2.50M	1.48M	—
Working Capital	18.60M	19.56M	4.28M	3.02M

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Assets
Cash & Equivalents	10.84M	18.24M	3.68M	5.74M
Cash & Short-Term Investments	10.84M	18.24M	3.68M	5.74M
Receivables	809.77K	621.75K	343.34K	317.54K
Inventory	3.56M	1.72M	1.50M	0.68M
Current Assets	20.60M	21.20M	5.80M	7.39M
PP&E	15.04M	12.08M	12.86M	7.51M
Total Assets	35.65M	33.28M	18.66M	14.90M
Liabilities
Accounts Payable	251.10K	272.68K	340.97K	441.25K
Current Liabilities	2.01M	1.64M	1.52M	4.37M
Total Debt	1.51M	1.80M	1.93M	2.62M
Total Liabilities	4.76M	4.36M	4.27M	7.54M
Equity & Ownership
Retained Earnings	5.89M	6.27M	4.39M	2.46M
Total Equity	30.89M	28.92M	14.39M	7.36M
Net Debt	-9.33M	-16.44M	-1.75M	-3.11M
Shares Outstanding	2,500,000	2,500,000	1,481,420	—
Cash & Assets
Total Assets	35.65M	33.28M	18.66M	14.90M
Total Current Assets	20.60M	21.20M	5.80M	7.39M
Cash & Equivalents	10.84M	18.24M	3.68M	5.74M
Cash & Short-Term Investments	10.84M	18.24M	3.68M	5.74M
Net Cash (Debt)	9.33M	16.44M	1.75M	3.11M
Net Cash Per Share	3.73	6.58	1.19	—
Cash Growth	-40.6%	+396.0%	-35.9%	—
Net Cash Growth	-43.2%	+838.0%	-43.7%	—
Accounts Receivable	698.96K	341.67K	302.21K	299.64K
Other Receivables	110.80K	280.08K	41.13K	17.90K
Receivables	809.77K	621.75K	343.34K	317.54K
Inventory	3.56M	1.72M	1.50M	0.68M
Prepaid Expenses	73.25K	25.98K	—	—
Construction In Progress	1.24M	—	—	—
Land	7.79M	5.13M	5.13M	—
Buildings	3.36M	3.36M	3.36M	—
Machinery	6.71M	6.46M	6.27M	6.17M
Leasehold Improvements	1.14M	1.13M	1.11M	2.55M
Property, Plant & Equipment	15.04M	12.08M	12.86M	7.51M
Other Current Assets	5.31M	0.59M	0.28M	0.66M
Long-Term Leases	1.29M	1.50M	1.69M	2.13M
Current Portion of Leases	227.23K	308.48K	234.94K	497.36K
Liabilities & Obligations
Total Liabilities	4.76M	4.36M	4.27M	7.54M
Total Liabilities & Equity	35.65M	33.28M	18.66M	14.90M
Total Current Liabilities	2.01M	1.64M	1.52M	4.37M
Accounts Payable	251.10K	272.68K	340.97K	441.25K
Accrued Expenses	983.21K	793.62K	842.32K	621.62K
Current Income Taxes Payable	546.88K	264.20K	96.75K	120.54K
Other Current Liabilities	—	—	0.01M	2.69M
Pension & Post-Retirement Benefits	1.46M	1.23M	1.06M	1.04M
Debt & Funding
Total Debt	1.51M	1.80M	1.93M	2.62M
Equity & Book Value
Shareholders' Equity	30.89M	28.92M	14.39M	7.36M
Common Stock	25.00M	12.50M	10.00M	4.90M
Additional Paid-In Capital	—	10.15M	—	—
Retained Earnings	5.89M	6.27M	4.39M	2.46M
Book Value Per Share	12.36	11.57	9.71	—
Tangible Book Value	30.89M	28.92M	14.39M	7.36M
Tangible Book Value Per Share	12.36	11.57	9.71	—
Filing Date Shares Outstanding	2.50M	2.50M	1.48M	—
Total Common Shares Outstanding	2.50M	2.50M	1.48M	—
Working Capital	18.60M	19.56M	4.28M	3.02M